InvestorsHub Logo
icon url

survivor1x

05/31/19 3:23 PM

#230114 RE: beartrap12 #230102

Yes looks like that lemon is being turned into lemonade. Certainly looks like they can determine how much of the enhancement is immune cells. Which does two things. 1 removes a patient from the progressed column and 2. Shows you that actually the stuff is working SO KEEP DOING. Don't discontinue because you think it is progression and try another trick from your bag.

While it's only 3 patients the theory appears to be pretty solid and could serve as a tool to stop Direct trials early or tweak certain patients that are not showing immune infiltration. I think this is very important.
icon url

Lorie3168

05/31/19 5:46 PM

#230158 RE: beartrap12 #230102

Thanks for sharing. It surely looks like our beloved, astounding, brilliant neurosurgeon Dr Liau will become known as a pioneer in immunotherapy, as well as, neuroscience. Does any other longs get goosebumps when you think of being part of all of this, even if it is only through shares in a little biotech?
icon url

survivor1x

05/31/19 7:47 PM

#230170 RE: beartrap12 #230102

I like the whole part about "predictive biomarker" You know for future trials and such with ALL SOLID TUMORS.
icon url

survivor1x

05/31/19 7:52 PM

#230172 RE: beartrap12 #230102

You know what is missing from this immaging trial?......

I saw no reference to grapefruit juice.

Maybe the neuro surgery dept at St(crap)at news is working on a diagnostic tool to detect that.